Strattera is a medical product of the new generation which is prescribed for the treatment of the attention deficit hyperactivity disorder. It contains an active ingredient Atomoxetine.
Unlike Ritalin, Strattera is better tolerated, does not provide a side effect, and works well for children. The mechanism of the action of Strattera consists in the modification of the behavior by means of the selective action to the receptors of noradrenaline.
Strattera is not a psychostimulant, and therefore it acts softly, does not cause a medical addition, and can be used for a long time. This drug reduces the symptoms of the attention deficit and hyperactivity disorder and helps to restore all functions of the brain which have been affected as a result of this disease.
Atomoxetine is quickly and completely absorbed after the oral use, gaining the maximal concentration in 1-2 hours. It is not accumulated in the body and is excreted by kidneys in about 4-6 hours.
Indications for the use
- Attention Deficit Hyperactivity Disorder
- Increased aggressiveness in children
- coordination disorder in children
- Decreased memory, attentiveness and others.
In what dose should be Strattera used?
The dose of Strattera depends on the symptoms of the disease and age/body weight of the patient. Adults should take Strattera in high doses: 40-120 mg per day. The treatment begins with 40 mg of Strattera per day, and then the dose is increased up to 80-120 mg depending on the severity of the symptoms.
The dose of Strattera is lower for children and depends on the body weight of a child. The standard daily dose of Strattera is 0,5-1,2 mg per 1 kg of the body weight per day for children (not more than 120 mg).
The daily dose is better used once, in the morning, before or during breakfast. If a patient has side effects, the daily dose can be divided into 2 times and Strattera is used every 12 hours.
Contraindications for the use
- angle-closure glaucoma
- severe damage of the heart and blood vessels
- cerebrovascular disturbance
- Age under 6 years
- Strattera is not recommended to be used with psychostimulants. Despite their differences in the chemical structure, the mechanism of the action is similar, so that the side effects can appear
- The simultaneous use of Strattera with MAO inhibitors is contraindicated
- Strattera should be carefully used in combination with hypotensive products because of the possible effect to the blood pressure
- Probable side effects
The probability of the side effect is lower during the use of Strattera than using psychostimulants. However, some patients can experience the following side effects: dyspepsia, dry mouth, rapid change in blood pressure, loss of appetite, decreased libido, urinary retention, tachycardia, and mania.
The side effects of Strattera often appear within the first or second week of the treatment, and then they pass. In order to reduce the side effect, it is possible to temporarily lower the dose.
In case of the overdose with Strattera, the side effects become stronger: severe drowsiness or excitement, blurred vision, convulsions, and vomiting. If these side effects appeared, go to a doctor and have a stomach-lavage.